Lex Fridman Podcast #93 – Daphne Koller: Biomedicine and Machine Learning
18 snips
May 5, 2020 Daphne Koller, a powerhouse in computer science and biomedicine, discusses the future of healthcare as the CEO of Insitro and co-founder of Coursera. She explores the potential for curing diseases and extends conversations on longevity, emphasizing the complexities of aging and health. Koller's insights on machine learning revolutionizing drug discovery highlight the promise of innovative techniques like CRISPR. Her personal journey in medicine and views on education's evolution add depth, urging listeners to embrace technology for a healthier future.
AI Snips
Chapters
Transcript
Episode notes
Curing Disease Is Hard
- Curing diseases is challenging, especially when discovered late, as damage is already done.
- True cures are rare; we mostly offer treatments, highlighting the complexity of regenerating the body.
Varying Disease Understanding
- Our disease understanding varies greatly; some are at 70-80%, while others are near 0%.
- Diseases like Alzheimer's, schizophrenia, and even type 2 diabetes likely comprise multiple distinct mechanisms.
Disease and Longevity Overlap
- Disease and longevity overlap, with disease risk increasing exponentially after age 40.
- However, they aren't identical; some aging isn't disease-related, and some diseases aren't age-related.